Here's Why You Should Buy Matador (MTDR) Stock Right Now
https://www.zacks.com/stock/news/2193093/here-s-why-you-should-buy-matador-mtdr-stock-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193093
Dec 04, 2023 - Matador (MTDR) anticipates concluding this year on a robust note, driven by sustained production growth, operational cost efficiencies and progress in debt repayment.
0
GSK vs. VRTX: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2193083/gsk-vs-vrtx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2193083
Dec 04, 2023 - GSK vs. VRTX: Which Stock Is the Better Value Option?
0
STNG or KEX: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2193086/stng-or-kex-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2193086
Dec 04, 2023 - STNG vs. KEX: Which Stock Is the Better Value Option?
0
Missed Out on Nvidia? 2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Now
https://www.fool.com/investing/2023/12/04/missed-out-on-nvidia-2-no-brainer-artificial-intel/?source=iedfolrf0000001
Dec 04, 2023 - It is time to strengthen your portfolio with these two solid artificial intelligence stocks.
0
Should Investors Hold Onto Healthpeak (PEAK) Stock for Now?
https://www.zacks.com/stock/news/2193048/should-investors-hold-onto-healthpeak-peak-stock-for-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2193048
Dec 04, 2023 - Healthpeak (PEAK) is poised to gain from the robust demand for lab assets and rising senior citizens' healthcare expenditure. However, competition from peers and high interest rates are woes.
0
Here's Why Investors Should Hold Union Pacific (UNP) Now
https://www.zacks.com/stock/news/2193014/here-s-why-investors-should-hold-union-pacific-unp-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193014
Dec 04, 2023 - Investor-friendly steps and cost-control efforts boost Union Pacific (UNP).
0
Here's Why ImmunityBio (IBRX) Is a Great 'Buy the Bottom' Stock Now
https://www.zacks.com/stock/news/2192998/here-s-why-immunitybio-ibrx-is-a-great-buy-the-bottom-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2192998
Dec 04, 2023 - After losing some value lately, a hammer chart pattern has been formed for ImmunityBio (IBRX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
0
Is Old Second Bancorp (OSBC) a Great Value Stock Right Now?
https://www.zacks.com/stock/news/2192937/is-old-second-bancorp-osbc-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2192937
Dec 04, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Are Investors Undervaluing TopBuild (BLD) Right Now?
https://www.zacks.com/stock/news/2192943/are-investors-undervaluing-topbuild-bld-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2192943
Dec 04, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Are Investors Undervaluing Concentrix (CNXC) Right Now?
https://www.zacks.com/stock/news/2192939/are-investors-undervaluing-concentrix-cnxc-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2192939
Dec 04, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0